Assembly Biosciences, Inc. (ASMB) financial statements (2021 and earlier)

Company profile

Business Address 331 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments216274218120536829
Cash and cash equivalents59474182292729
Short-term investments157227177382441 
Receivables1322   
Other current assets     10
Other undisclosed current assets75211  
Total current assets:224283223123546829
Noncurrent Assets
Operating lease, right-of-use asset912
Property, plant and equipment2211000
Long-term investments and receivables   3223 
Long-term investments   3223 
Intangible assets, net (including goodwill)42424242424242
Goodwill13131313131313
Intangible assets, net (excluding goodwill)29292929292929
Other noncurrent assets623    
Other undisclosed noncurrent assets   0000
Total noncurrent assets:59574646456542
TOTAL ASSETS:2833402681699813471
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1710106520
Accounts payable52     
Accrued liabilities128106520
Deferred revenue 6
Debt 3     
Deferred revenue and credits5   
Deferred tax liabilities3   12
Other undisclosed current liabilities856221(11)
Total current liabilities:24241813731
Noncurrent Liabilities
Long-term debt and lease obligation79     
Operating lease, liability79
Liabilities, other than long-term debt1233041   
Deferred revenue and credits41   
Deferred revenue931
Deferred rent credit  0
Deferred income tax liabilities33
Other undisclosed noncurrent liabilities  392111212
Total noncurrent liabilities:18423943111212
Total liabilities:43675756181513
Stockholders' equity
Stockholders' equity attributable to parent2412732111138011959
Common stock0000000
Additional paid in capital742713553365289284194
Accumulated other comprehensive loss(0)(0)(0)(0)(1)(1) 
Accumulated deficit(502)(439)(342)(251)(208)(164)(136)
Total stockholders' equity:2412732111138011959
TOTAL LIABILITIES AND EQUITY:2833402681699813471

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues7916159   
Revenue, net9   
Cost of revenue
(Cost of Goods and Services Sold)
   (5)   
Gross profit:7916154   
Operating expenses(144)(119)(108)(61)(45)(30)(37)
Other undisclosed operating income   5  13
Operating loss:(65)(103)(93)(52)(45)(30)(24)
Nonoperating income3430010
Investment income, nonoperating  000(1) 
Loss from continuing operations before income taxes:(62)(98)(90)(52)(45)(28)(24)
Income tax expense (benefit) 1(1)91  
Net loss available to common stockholders, diluted:(62)(98)(91)(43)(44)(28)(24)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(62)(98)(91)(43)(44)(28)(24)
Other comprehensive loss   (0)(0)  
Comprehensive loss:(62)(98)(91)(43)(45)(28)(24)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0001(1) 
Comprehensive loss, net of tax, attributable to parent:(62)(97)(91)(43)(44)(29)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: